Search Results - Markus Falk

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Activity of afatinib in patients with NSCLC harboring novel uncommon EGFR mutations with or without co-mutations: a case report by Petros Christopoulos, Petros Christopoulos, Franziska Herster, Petra Hoffknecht, Markus Falk, Markus Falk, Markus Tiemann, Markus Tiemann, Hans-Georg Kopp, Andre Althoff, Anja Stammberger, Eckart Laack

    Published in Frontiers in Oncology (2024-05-01)
    Get full text
    Article


  2. 2

    Evaluation of the Prognostic Impact of SP263-Evaluated PD-L1 Expression in Patients with Stage III Non-Small Cell Lung Cancer (NSLC) Treated with Radio-Chemotherapy by Jan Nicolai Wagner, Julia Roeper, Lukas Heukamp, Markus Falk, Kay Willborn, Frank Griesinger

    Published in Biomedicines (2024-03-01)
    Get full text
    Article


  3. 3

    Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy by Balázs Jóri, Markus Falk, Iris Hövel, Peggy Weist, Markus Tiemann, Lukas C. Heukamp, Frank Griesinger

    Published in Current Oncology (2022-09-01)
    Get full text
    Article


  4. 4

    Neonatal Resuscitation With T-Piece Systems: Risk of Inadvertent PEEP Related to Mechanical Properties by Thomas Drevhammar, Markus Falk, Snorri Donaldsson, Snorri Donaldsson, Mark Tracy, Mark Tracy, Murray Hinder, Murray Hinder

    Published in Frontiers in Pediatrics (2021-06-01)
    Get full text
    Article


  5. 5

    Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy by Markus Falk, Eva Willing, Stefanie Schmidt, Stefanie Schatz, Marco Galster, Markus Tiemann, Joachim H. Ficker, Wolfgang M. Brueckl

    Published in Current Oncology (2023-01-01)
    Get full text
    Article


  6. 6

    The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations by Balázs Jóri, Christine Vössing, Judith Pirngruber, Eva Maria Willing, Kathrin Arndt, Markus Falk, Markus Tiemann, Lukas C. Heukamp, Petra Hoffknecht

    Published in Current Oncology (2023-09-01)
    Get full text
    Article


  7. 7

    Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report by Markus Falk, Stefanie Schatz, Fabian P. M. Reich, Stefanie Schmidt, Marco Galster, Markus Tiemann, Joachim H. Ficker, Wolfgang M. Brueckl

    Published in Current Oncology (2023-09-01)
    Get full text
    Article


  8. 8

    Hypothermia-Associated Coagulopathy: A Comparison of Viscoelastic Monitoring, Platelet Function, and Real Time Live Confocal Microscopy at Low Blood Temperatures, an in vitro Exper... by Bernd Wallner, Bernd Wallner, Bernd Wallner, Bettina Schenk, Martin Hermann, Peter Paal, Markus Falk, Giacomo Strapazzon, Wenjun Z. Martini, Hermann Brugger, Dietmar Fries

    Published in Frontiers in Physiology (2020-07-01)
    Get full text
    Article


  9. 9

    The Effect of Automated Verbal Commands During Avalanche Transceiver Search on Acute Mental Stress and Arousal—A Mixed‐Methods Crossover Field Study by Bernd Wallner, Fabio Caramazza, Simon Woyke, Manuel Winkler, Ivo B. Regli, Peter Mair, Gabriel Putzer, Giacomo Strapazzon, Markus Falk, Hermann Brugger, Katharina Hüfner

    Published in Brain and Behavior (2025-07-01)
    Get full text
    Article


  10. 10

    Avalanche transceiver search times during avalanche companion rescue – A prospective randomized single-blinded cross-over simulation study by Bernd Wallner, Simon Woyke, Manuel Winkler, Fabio Caramazza, Ivo B. Regli, Gabriel Putzer, Giacomo Strapazzon, Markus Falk, Hermann Brugger, Katharina Hüfner, Peter Mair

    Published in Resuscitation Plus (2025-11-01)
    Get full text
    Article


  11. 11

    Effect of oxygen supplementation on cognitive performance among HEMS providers after acute exposure to altitude: the HEMS II randomized clinical trial by Marika Falla, Michiel J. van Veelen, Markus Falk, Elisabeth M. Weiss, Giulia Roveri, Michela Masè, Bernhard Weber, Anna Randi, Hermann Brugger, Katharina Hüfner, Giacomo Strapazzon

    Get full text
    Article


  12. 12

    Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors by Svenja Wagener-Ryczek, Carina Heydt, Juliane Süptitz, Sebastian Michels, Markus Falk, Christina Alidousty, Jana Fassunke, Michaela Angelika Ihle, Markus Tiemann, Lukas Heukamp, Jürgen Wolf, Reinhard Büttner, Sabine Merkelbach-Bruse

    Published in BMC Cancer (2020-05-01)
    Get full text
    Article


Search Tools: